Partial upper sternotomy vs full median sternotomy in obese patients undergoing aortic valve replacement: A meta-analysis

肥胖患者行主动脉瓣置换术时,部分上胸骨切开术与全正中胸骨切开术的比较:一项荟萃分析

阅读:1

Abstract

BACKGROUND: Obese patients (body mass index ≥ 30 kg/m²) undergoing isolated aortic valve replacement (AVR) face increased surgical risks due to comorbidities. Partial upper sternotomy (PUS), a minimally invasive approach, may reduce complications compared to full median sternotomy (FMS). We hypothesize that PUS improves outcomes over FMS in obese patients undergoing AVR. AIM: To compare the efficacy and safety of PUS vs FMS in obese patients undergoing isolated AVR. METHODS: This systematic review and meta-analysis followed PRISMA guidelines, searching PubMed, EMBASE, and Cochrane databases for observational studies comparing PUS vs FMS in obese patients undergoing AVR. Outcomes were analyzed using odds ratios (OR), mean differences (MD), 95% confidence intervals (CI), I² statistic, and Newcastle-Ottawa Scale was used for quality assessment. RESULTS: Four observational studies involving 677 patients were analyzed. PUS reduced intensive care unit stay (MD -2.67 days, 95%CI: -4.43 to -0.90, P = 0.003, I² = 78%) but increased cardiopulmonary bypass time (MD 5.62 minutes, 95%CI: -0.36 to 11.59, I² = 55%). No differences were observed in renal failure (OR 1.13, 95%CI: 0.63-2.94, I² = 0%), atrial fibrillation (OR 0.81, 95%CI: 0.43-1.54, I² = 30%), reexploration (OR 1.09, 95%CI: 0.48-2.47, I² = 0%), postoperative bleeding (OR 1.48, 95%CI: 0.53-4.15, I² = 60%), wound infection (OR 1.23, 95%CI: 0.70-2.14, I² = 0%), hospital stay (MD 0.51 days, 95%CI: -4.13 to 5.15, I² = 90%), or cross-clamp time (MD 4.03 minutes, 95%CI: -0.75 to 8.80, I² = 50%). CONCLUSION: PUS is safe and effective for obese patients undergoing AVR, reducing intensive care unit stay and enhancing recovery, provided surgical expertise is available.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。